Currently, MDM2 gene amplification and/or protein overexpression in human cancers are assessed by ex vivo methods, such as fluorescence in-situ hybridization (FISH) and immunohistochemical (IHC) staining of tumor biopsy material [18,19]. The gene discussed is MDM2; the disease is cancer.